![Victor Sandor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 478 332 $ in data 31/05/2026
Victor Sandor is currently an Independent Non-Executive Director at ADC Therapeutics SA since 2020, an Independent Director at Prelude Therapeutics, Inc. since 2020, an Independent Director at Kymera Therapeutics, Inc. since 2022, a Director at Istari Oncology, Inc. since 2019, and an Independent Director at AbCellera Biologics, Inc. starting in 2026.
Former roles include Independent Non-Executive Director at Merus NV from 2019 to 2025, SVP-Global Clinical Development at Incyte Corp.
from 2014 to 2019, Chief Medical Officer at Array BioPharma, Inc. from 2014 to 2019, Head-Oncology Product Development at AstraZeneca, Inc., and Chief Medical Officer-Oncology & VP at Biogen Idec, Inc. (North Carolina) from 2010 to 2014.
Education includes a doctorate from McGill University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 0,11% | 03/06/2026 | 140.686 ( 0,11% ) | 478 332 $ | 31/05/2026 |
| 27/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ADC THERAPEUTICS SA | Direttore/Membro del Consiglio | 27/04/2020 |
| PRELUDE THERAPEUTICS INCORPORATED | Direttore/Membro del Consiglio | 01/05/2020 |
| KYMERA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/11/2022 |
| ABCELLERA BIOLOGICS INC. | Direttore/Membro del Consiglio | 01/06/2026 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Direttore/Membro del Consiglio | 01/07/2019 |
| Società | Posizione | Fine |
|---|---|---|
| MERUS N.V. | Direttore/Membro del Consiglio | 12/12/2025 |
| INCYTE CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/09/2019 |
| ARRAY TECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2019 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/09/2014 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
